Effect of valproate on plasma levels of interleukin-6 in healthy male humans

International Clinical Psychopharmacology

Volumn 20, Issue 6, 2005, Pages 295-298

  Shiah, I Shin ^a   Yatham, Lakshmi N ^b   Yeh, Chin Bin ^a   Ravindran, Arun V ^c  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Cytokines; Immune function; Interleukin 6; Valproate

Indexed keywords

INTERLEUKIN 6; VALPROIC ACID;

ADULT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DIARRHEA; DROWSINESS; DRUG BLOOD LEVEL; DRUG EFFECT; FATIGUE; GINGIVA BLEEDING; HEADACHE; HUMAN; HUMAN EXPERIMENT; MALE; NAUSEA; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; VOMITING;

ADULT; ANTIMANIC AGENTS; HUMANS; IMMUNE SYSTEM; INTERLEUKIN-6; MALE; VALPROIC ACID;

EID: 26944478558     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004850-200511000-00002     Document Type: Article

References (25)

1. Bock GR, Marsh J, Widdows K (1992). Polyfunctional Cytokines: IL-6 and LIF. Chichester: John Wiley & Sons.
2. Bowden CL (2003). Valproate. Bipolar Disord 5:189-202.
3. Camargo AC, Caldo H, Emson PC (1983). Degradation of neurotensin by rabbit brain endo-oligopeptidase A and endo-oligopeptidase B proline-endopeptidase). Biochem Biophys Res Commun 116: 1151-1159.
4. De Sarro GB, Berlinghieri MC, Elia M, Musumeci SA, David E, Dominijanni A, Gulletta E (1998). Does antiepileptic therapy affect immune response? J Chemother 10:184-186.
5. First MB, Spitzer RL, Gibbon M, Williams JBW (1997). Structured Clinical Interview for DSM-IV, Axis I Disorders (SCID-I), Clinician Version. Washington, DC: American Psychiatric Association.
6. Fujiwara K, Yoshida A, Ochi M (1983). Serum immunoglobulin levels in children receiving valproic acid. Brain Dev 5:199.
7. Garzon P, Gonzalez-Cornejo S, Roman-Maldonado S, Navarro-Ruiz A (1985). Valproic acid and phenytoin effects on serum proteins and immunoglobulins of epileptic patients. Gen Pharmacol 16: 411-413.
8. Heinrich PC, Castell JV, Andus T (1990). Interleukin-6 and the acute phase response. Biochem J 265:621-636.
9. Ichiyama T, Okada K, Lipton JM, Matsubara T, Hayashi T, Furukawa S (2000). Sodium valproate inhibits production of TNF-alpha and IL-6 and activation of NF-kappaB. Brain Res 857:246-251.
10. Joubert PH, Aucamp AK, Potgieter GM, Verster F (1977). Epilepsy and IgA deficiency-the effect of sodium valproate. S Afr Med J 52: 642-644.
11. Kato T, Okada M, Nagatsu T (1980). Distribution of post-proline cleaving enzyme in human brain and the peripheral tissues. Mol Cell Biochem 32:117-121.
12. Kushner I (1991). The acute phase response: from Hippocrates to cytokine biology. Eur Cytokine Netw 2:75-80.
13. Lenti C, Masserini C, Peruzzi C, Guareschi Cazzullo A (1991). Effects of carbamazepine and valproate on immunological assessment in young epileptic patients. Ital J Neurol Sci 12:87-91.
14. Leu SJ, Shiah IS, Yatham LN, Cheu YM, Lam RW (2001). Immune-inflammatory markers in patients with seasonal affective disorder: effects of light therapy. J Affect Disord 63:27-34.
15. Loscher W (1993). Effects of the antiepileptic drug valproate on metabolism and function of inhibitory and excitatory amino acids in the brain. Neurochem Res 18:485-502.
16. Maes M, Bosmans E, Calabrese J, Smith R, Meltzer HY (1995a). Interleukin-2 and interleukin-6 in schizophrenia and mania: effects of neuroleptics and mood stabilizers. J Psychiatr Res 29:141-152.
17. Maes M, Goossens F, Scharpe S, Calabrese J, Desnyder R, Meltzer HY (1995b). Alterations in plasma prolyl endopeptidase activity in depression, mania, and schizophrenia: effects of antidepressants, mood stabilizers, and antipsychotic drugs. Psychiatry Res 58:217-225.
18. Maes M, Goossens F, Scharpe S, Meltzer HY, D'Hondt P, Cosyns P (1994). Lower serum prolyl endopeptidase enzyme activity in major depression: further evidence that peptidases play a role in the pathophysiology of depression. Biol Psychiatry 35:545-552.
19. Pacifici R, Paris L, Di Carlo S, Bacosi A, Pichini S, Zuccaro P (1995). Cytokine production in blood mononuclear cells from epileptic patients. Epilepsia 36:384-387.
20. Queiroz ML, Mullen PW (1992). Effects of sodium valproate on the immune response. Int J Immunopharmacol 14:1133-1137.
21. Song C, Leonard BE (2000). Fundamentals of Psyhchoneuroimmunology. Chichester: John Wiley & Sons.
22. Verrotti A, Basciani F, Trotta D, Greco R, Morgese G, Chiarelli F (2001). Effect of anticonvulsant drugs on interleukins-1, -2 and -6 and monocyte chemoattractant protein-1. Clin Exp Med 1:133-136.
23. Ward PE, Bausback HH, Odya CE (1987). Kinin and angiotensin metabolism by purified renal post-proline cleaving enzyme. Biochem Pharmacol 36:3187-3193.
24. Wilk S (1983). Prolyl endopeptidase. Life Sci 33:2149-2157.
25. Yirmiya R (1997). Behavioral and psychological effects on immune activation: implications for 'depression due to a general medical condition'. Curr Opin Psychiatry 10:470-476.